BusinessMyriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with OlaparibBy Nasdaq OMXOct 26, 2016, 11:15 AM UTC
BusinessMerus Expands Executive Management Team with the Appointment of L. Andres Sirulnik, MD, PhD, as Chief Medical OfficerBy Nasdaq OMXOct 26, 2016, 11:00 AM UTC
BusinessNewLink Genetics Shares Its Immuno-Oncology Strategy 2016 Analyst and Investor DayBy Nasdaq OMXOct 25, 2016, 8:08 PM UTC
BusinessMyriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with DiabetesBy Nasdaq OMXOct 25, 2016, 11:05 AM UTC
BusinessNewLink Genetics to Host Its Third Quarter 2016 Financial Results Conference Call on November 1, 2016By Nasdaq OMXOct 24, 2016, 11:00 AM UTC
BusinessCytoDyn Files Protocol for Extended Access to PRO 140 for Patients Who Reach the End of PRO 140 Pivotal Phase 3 TrialBy Nasdaq OMXOct 24, 2016, 10:30 AM UTC
BusinessAir Methods to Report Third Quarter 2016 Financial Results on Thursday, November 3, 2016By Nasdaq OMXOct 21, 2016, 1:01 PM UTC
BusinessApricus Biosciences Announces 1-for-10 Reverse Stock SplitBy Nasdaq OMXOct 20, 2016, 8:30 PM UTC
